Month: June 2018

Month: June 2018

CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease

By

Updated: September 12, 2018

OAKVILLE, Ontario, June 28, 2018 /PRNewswire/ — The CHILD-BRIGHT Network, a Canadian patient-oriented research network focussed on pediatric brain-based developmental disorders, and Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced the start of enrollment for the CHILD-BRIGHT Mega Team research project trial, a Canadian-developed video game-based cognitive intervention that aims to improve executive functions in children with brain-based developmental disabilities such as Attention Deficit and Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), or born with a Congenital Heart Defect (CHD).

Category: News & Events

Canada House Wellness Group’s Licensed Cannabis Producer Abba Medix Receives First Sales License from Health Canada

By

Posted: June 23, 2018

TORONTO, July 23, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. (“Abba”), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) has successfully completed its Health Canada pre-sales inspection and has received an amendment to its Producer’s Licence from Health Canada to include the sale and provision of marihuana seeds, effective July 20, 2018.

Category: News & Events

FSD Pharma Inc. Announces a Partnership Agreement with Cannara Biotech Inc. to Allow for Indoor Grow Space to Increase to a Combined 1,245,000 Square Feet

By

Updated: September 12, 2018

TORONTO, June 19, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or “The Company”) (CSE:HUGE), announced the signing of a partnership agreement between FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of the Company, and Cannara Biotech Inc. (“Cannara”) effective May 31, 2018. The agreement creates the ability for the Company to  become the largest indoor medical cannabis growing operation in North America. Together, FV Pharma and Cannara have a combined floor space of over 1.245 million square feet of indoor growing capacity.

Category: News & Events

NuRAN Wireless and Avanti Communications Sign Partnership Agreement

By

Updated: September 13, 2018

QUEBEC CITY, June 19, 2018 (GLOBE NEWSWIRE) — NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE:NUR) (OTC:NRRWF) (FSE:1RN) is pleased to announce that it has signed an MOU with Avanti Communications Group plc (“Avanti”), [AIM (AVN:LSE)] to market and distribute a combined 2G RAN product alongside Avanti’s Ka-band satellite backhaul solution.

Category: News & Events